VEA - ETF AI Analysis
Top Page
Vanguard FTSE Developed Markets ETF (VEA)
Rating:59Neutral
Price Target:―
Positive Factors
Broad Country Diversification
The ETF spreads its investments across many developed markets like Japan, the UK, Europe, Canada, and others, which helps reduce the impact of problems in any single country.
Low Expense Ratio
The fund charges very low annual fees, so more of the investment returns stay in investors’ pockets over time.
Generally Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating supportive market conditions for its developed-market holdings.
Negative Factors
Exposure to Weak Top Holdings
A few of the largest positions, such as Roche, Nestlé, and Toyota, have shown weaker recent performance, which can drag on overall returns.
Heavy Weight in Financials
A sizable allocation to financial companies means the fund can be more sensitive to changes in interest rates and banking sector stress.
Limited U.S. Market Exposure
The ETF focuses mainly on non-U.S. developed markets, so investors relying on it alone may miss out on periods when U.S. stocks are leading global performance.
VEA vs. SPDR S&P 500 ETF (SPY)
AUM231.24B
RegionDeveloped Markets
Expense Ratio0.03%
Beta0.79
IssuerVanguard
Inception DateJul 20, 2007
Dividend Yield2.71%
Asset ClassEquity
Index TrackedFTSE Developed ex US All Cap Net Tax (US RIC) Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume9,421,205
30 Day Avg. Volume14,016,264
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.31Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3789
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VEA Summary
Vanguard FTSE Developed Markets ETF (VEA) is an international stock fund that tracks the FTSE Developed All Cap ex US Index, focusing on developed countries outside the United States. It owns thousands of companies across Europe, Asia, and Australia, including well-known names like Nestlé, Toyota, and Shell. Investors might consider VEA to diversify beyond the U.S. market and seek long-term growth from established global economies in one simple investment. A key risk is that international stock prices can be volatile and can go up or down with global markets and currency movements.
How much will it cost me?The Vanguard FTSE Developed Markets ETF (VEA) has an expense ratio of 0.03%, meaning you’ll pay $0.30 per year for every $1,000 invested. This is much lower than average because it’s a passively managed fund that tracks an index, keeping costs minimal.
What would affect this ETF?The Vanguard FTSE Developed Markets ETF (VEA) could benefit from economic growth in developed markets outside North America, particularly if sectors like financials, technology, and healthcare continue to perform well. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in key regions like Europe and Asia could negatively impact its holdings and overall performance.
VEA Top 10 Holdings
VEA’s story is all about broad developed markets outside the U.S., with a clear tilt toward European heavyweights and global banks. ASML has been the star of the show, rising strongly and giving the fund a tech-powered boost, while HSBC and Royal Bank of Canada add steady tailwinds from the financial side. On the flip side, pharma giants like AstraZeneca and Roche have been more mixed, and Nestlé has lost a bit of its defensive shine. Overall, performance is driven by a global mix, not any single sector or country.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 2.24% | $6.92B | ― | ― | ― | |
| ASML Holding NV | 1.77% | $5.46B | €572.21B | 118.80% | 76 Outperform | |
| ― | 1.52% | $4.70B | ― | ― | ― | |
| HSBC Holdings | 1.00% | $3.07B | £234.90B | 54.34% | 80 Outperform | |
| Roche Holding AG | 0.90% | $2.79B | CHF258.92B | 26.36% | 73 Outperform | |
| AstraZeneca | 0.90% | $2.77B | £210.20B | 28.53% | 80 Outperform | |
| Novartis AG | 0.89% | $2.76B | CHF211.48B | 21.53% | 80 Outperform | |
| Nestlé SA | 0.82% | $2.53B | CHF197.24B | -7.64% | 71 Outperform | |
| Shell (UK) | 0.82% | $2.52B | £179.55B | 28.71% | 73 Outperform | |
| Royal Bank Of Canada | 0.79% | $2.45B | $271.57B | 52.15% | 75 Outperform |
VEA Technical Analysis
Positive
―
Price Trends
68.64
Positive
67.54
Positive
63.71
Positive
Market Momentum
0.69
Positive
44.30
Neutral
51.98
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VEA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 70.76, equal to the 50-day MA of 68.64, and equal to the 200-day MA of 63.71, indicating a neutral trend. The MACD of 0.69 indicates Positive momentum. The RSI at 44.30 is Neutral, neither overbought nor oversold. The STOCH value of 51.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VEA.
VEA Peer Comparison
Comparison Results
Performance Comparison
VEA
Vanguard FTSE Developed Markets ETF
69.17
14.60
26.75%
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
DFAI
Dimensional International Core Equity Market ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents